What Does ‘>99% Purity’ Actually Mean?

When a peptide supplier advertises “>99% purity,” it sounds definitive. But without context, that number is nearly meaningless. Purity is a measurement — and like all measurements, it depends entirely on the method used, the equipment calibrated, and who is doing the measuring.

In the RUO peptide market, purity claims range from rigorously verified third-party HPLC data to numbers that were simply typed into a product description with no supporting evidence. Understanding the difference is critical for any researcher who cares about reproducibility.

High-Performance Liquid Chromatography (HPLC) is the gold standard for measuring peptide purity. The process works by dissolving the peptide in a solvent and pushing it through a column packed with absorbent material. Different compounds travel through the column at different speeds, separating them into distinct peaks on a chromatogram.

The purity percentage is calculated as the area under the target compound’s peak divided by the total area under all peaks. A 99% purity reading means 99% of the detected material is your target peptide — and 1% is something else: impurities, truncated sequences, oxidized residues, or synthesis byproducts.

Key things to look for in an HPLC report:
• The retention time of the main peak (should be consistent batch-to-batch)
• The number and size of any secondary peaks (impurities)
• The wavelength used for detection (typically 214nm or 220nm for peptides)
• The column type and gradient conditions (affects what gets detected)

HPLC tells you how pure something is. Mass spectrometry (MS) tells you what it actually is. A compound can be 99% pure and still be the wrong compound — which is why both tests together are the real standard.

Mass spectrometry measures the mass-to-charge ratio of ionized molecules. For a peptide, the expected molecular weight can be calculated from its amino acid sequence. If the measured mass matches the theoretical mass within acceptable tolerance (typically ±1 Da), the compound’s identity is confirmed.

At BetterBio Synthesis, every batch receives both HPLC purity analysis AND mass spectrometry identity confirmation. Both results are published in the COA Library. If either test fails, the batch is rejected — not relabeled.

Many suppliers test their own products and publish those results as COAs. This is a fundamental conflict of interest. When the company selling you a product is also the company testing it, there is a direct financial incentive to produce favorable results.

Third-party testing removes this conflict entirely. An independent, accredited laboratory has no stake in the outcome. Their reputation depends on accurate results, not on making a supplier look good.

At BetterBio Synthesis, we never test our own products. Every COA is issued by an independent, accredited third-party laboratory. The lab’s name, accreditation number, and analyst signature appear on every report.

Our minimum acceptance criteria for any batch:
• HPLC purity: ≥99% (area percent at 214nm)
• Mass spectrometry: Confirmed molecular weight within ±1 Da of theoretical
• Endotoxin: <1 EU/mg (LAL method)
• Residual solvents: Below ICH Q3C Class 2 limits
• Appearance: White to off-white lyophilized powder

If a batch misses any of these criteria, it is not sold. Period.